Medtronic (MDT) — insider trading
Health Care · NYSE
Medtronic (MDT) has 16 reported SEC Form 4 insider transactions in our data, including 3 open-market sales among the most recent 16 (latest 2026-07-08).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-08 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Open-market sale | 3,102 | $83.15 | $257.9K | Form 4 |
| 2026-06-08 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Open-market sale | 228 | $80.45 | $18.3K | Form 4 |
| 2026-06-08 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Open-market sale | 3,961 | $80.44 | $318.6K | Form 4 |
| 2026-06-05 | Blomquist Denise L. | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 237 | $83.32 | $19.7K | Form 4 |
| 2026-06-04 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Shares withheld for taxes / exercise cost | 2,840 | $83.32 | $236.6K | Form 4 |
| 2026-06-04 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Shares withheld for taxes / exercise cost | 7,471 | $83.32 | $622.5K | Form 4 |
| 2026-06-04 | Martha Geoffrey | Director, Officer (Chairman and CEO) | Shares withheld for taxes / exercise cost | 41,936 | $83.32 | $3.49M | Form 4 |
| 2026-06-04 | KIIL HARRY SKIP | Officer (EVP & President Cardiovascular) | Shares withheld for taxes / exercise cost | 6,817 | $83.32 | $568.0K | Form 4 |
| 2026-05-26 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Option exercise / conversion (derivative) | 17,093 | $0.00 | $0 | Form 4 |
| 2026-05-26 | Marinaro Michael | Officer (EVP, Pres MedSurg and Americas) | Option exercise / conversion | 18,994 | $0.00 | $0 | Form 4 |
| 2026-05-26 | Martha Geoffrey | Director, Officer (Chairman and CEO) | Option exercise / conversion (derivative) | 85,461 | $0.00 | $0 | Form 4 |
| 2026-05-26 | Martha Geoffrey | Director, Officer (Chairman and CEO) | Option exercise / conversion | 94,963 | $0.00 | $0 | Form 4 |
| 2026-05-26 | Wall Brett A. | Officer (EVP & Pres Neuroscience) | Option exercise / conversion (derivative) | 24,214 | $0.00 | $0 | Form 4 |
| 2026-05-26 | Wall Brett A. | Officer (EVP & Pres Neuroscience) | Option exercise / conversion | 26,907 | $0.00 | $0 | Form 4 |
| 2026-05-26 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Option exercise / conversion (derivative) | 8,449 | $0.00 | $0 | Form 4 |
| 2026-05-26 | Walter Matthew R. | Officer (SVP, Chief HR Officer) | Option exercise / conversion | 9,149 | $0.00 | $0 | Form 4 |
Ask the chat about MDT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Medtronic (MDT).
Last updated 2026-07-08 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.